Konstantin H. Dragnev, MD | Find a ...

Dr. Konstantin H. Dragnev

Claim this profile

Dartmouth Hitchcock Medical Center

Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
49 drugs studied

Area of expertise

1Lung Cancer
Global Leader
Konstantin H. Dragnev has run 13 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
PD-L1 positive
Stage III
2Non-Small Cell Lung Cancer
Konstantin H. Dragnev has run 8 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III

Affiliated Hospitals

Image of trial facility.
Dartmouth-Hitchcock Medical Center
Image of trial facility.
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center

Clinical Trials Konstantin H. Dragnev is currently running

More about Konstantin H. Dragnev

Clinical Trial Related6 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Konstantin H. Dragnev has experience with
  • Pembrolizumab
  • Carboplatin
  • Pemetrexed
  • Capivasertib
  • Vismodegib
  • Temozolomide

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Konstantin H. Dragnev specialize in?
Is Konstantin H. Dragnev currently recruiting for clinical trials?
Are there any treatments that Konstantin H. Dragnev has studied deeply?
What is the best way to schedule an appointment with Konstantin H. Dragnev?
What is the office address of Konstantin H. Dragnev?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security